JP5923445B2 - 緑内障の組み合わせ解析 - Google Patents
緑内障の組み合わせ解析 Download PDFInfo
- Publication number
- JP5923445B2 JP5923445B2 JP2012524139A JP2012524139A JP5923445B2 JP 5923445 B2 JP5923445 B2 JP 5923445B2 JP 2012524139 A JP2012524139 A JP 2012524139A JP 2012524139 A JP2012524139 A JP 2012524139A JP 5923445 B2 JP5923445 B2 JP 5923445B2
- Authority
- JP
- Japan
- Prior art keywords
- glaucoma
- analysis
- measurements
- visual field
- function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004458 analytical method Methods 0.000 title claims description 87
- 208000010412 Glaucoma Diseases 0.000 title description 118
- 238000005259 measurement Methods 0.000 claims description 145
- 238000012360 testing method Methods 0.000 claims description 127
- 230000000007 visual effect Effects 0.000 claims description 125
- 238000000034 method Methods 0.000 claims description 92
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 54
- 230000002207 retinal effect Effects 0.000 claims description 40
- 210000003994 retinal ganglion cell Anatomy 0.000 claims description 34
- 230000009466 transformation Effects 0.000 claims description 33
- 238000007689 inspection Methods 0.000 claims description 31
- 201000010099 disease Diseases 0.000 claims description 30
- 238000009826 distribution Methods 0.000 claims description 26
- 208000003098 Ganglion Cysts Diseases 0.000 claims description 19
- 208000005400 Synovial Cyst Diseases 0.000 claims description 19
- 238000003325 tomography Methods 0.000 claims description 17
- 230000003287 optical effect Effects 0.000 claims description 16
- 210000004027 cell Anatomy 0.000 claims description 12
- 238000000572 ellipsometry Methods 0.000 claims description 11
- 238000011207 functional examination Methods 0.000 claims description 6
- 230000006870 function Effects 0.000 description 82
- 238000006243 chemical reaction Methods 0.000 description 47
- 230000035945 sensitivity Effects 0.000 description 41
- 238000001514 detection method Methods 0.000 description 39
- 210000004126 nerve fiber Anatomy 0.000 description 37
- 238000002405 diagnostic procedure Methods 0.000 description 30
- 210000003733 optic disk Anatomy 0.000 description 29
- 208000035475 disorder Diseases 0.000 description 23
- 239000002131 composite material Substances 0.000 description 21
- 238000013459 approach Methods 0.000 description 20
- 238000010801 machine learning Methods 0.000 description 18
- 238000012549 training Methods 0.000 description 16
- 239000013598 vector Substances 0.000 description 15
- 230000008859 change Effects 0.000 description 14
- 238000003340 combinatorial analysis Methods 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- 238000003745 diagnosis Methods 0.000 description 10
- 238000013507 mapping Methods 0.000 description 10
- 210000001328 optic nerve Anatomy 0.000 description 9
- 230000003595 spectral effect Effects 0.000 description 9
- 206010047555 Visual field defect Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000011990 functional testing Methods 0.000 description 8
- 238000012706 support-vector machine Methods 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 7
- 230000001537 neural effect Effects 0.000 description 7
- 238000013102 re-test Methods 0.000 description 7
- 230000004382 visual function Effects 0.000 description 7
- 210000003050 axon Anatomy 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 230000002596 correlated effect Effects 0.000 description 6
- 230000006735 deficit Effects 0.000 description 6
- 230000010287 polarization Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 210000001525 retina Anatomy 0.000 description 6
- 238000000844 transformation Methods 0.000 description 6
- 206010003694 Atrophy Diseases 0.000 description 5
- 230000037444 atrophy Effects 0.000 description 5
- 230000005779 cell damage Effects 0.000 description 5
- 208000037887 cell injury Diseases 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 238000009499 grossing Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 210000002445 nipple Anatomy 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 230000004393 visual impairment Effects 0.000 description 5
- 208000002177 Cataract Diseases 0.000 description 4
- 208000033825 Chorioretinal atrophy Diseases 0.000 description 4
- 206010061818 Disease progression Diseases 0.000 description 4
- 206010047571 Visual impairment Diseases 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 230000005750 disease progression Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 238000012014 optical coherence tomography Methods 0.000 description 4
- 238000007781 pre-processing Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 208000029257 vision disease Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000006727 cell loss Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000030533 eye disease Diseases 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000000711 polarimetry Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000010038 Ischemic Optic Neuropathy Diseases 0.000 description 2
- 102000029749 Microtubule Human genes 0.000 description 2
- 108091022875 Microtubule Proteins 0.000 description 2
- 206010067013 Normal tension glaucoma Diseases 0.000 description 2
- 206010030924 Optic ischaemic neuropathy Diseases 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 206010067722 Toxic neuropathy Diseases 0.000 description 2
- 231100000126 Toxic neuropathy Toxicity 0.000 description 2
- 201000007058 anterior ischemic optic neuropathy Diseases 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 201000002978 low tension glaucoma Diseases 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 210000004688 microtubule Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000020911 optic nerve disease Diseases 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- RWIUTHWKQHRQNP-ZDVGBALWSA-N (9e,12e)-n-(1-phenylethyl)octadeca-9,12-dienamide Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(=O)NC(C)C1=CC=CC=C1 RWIUTHWKQHRQNP-ZDVGBALWSA-N 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 244000064816 Brassica oleracea var. acephala Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010052117 Corneal decompensation Diseases 0.000 description 1
- 102100033808 Glycoprotein hormone alpha-2 Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010027646 Miosis Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000030768 Optic nerve injury Diseases 0.000 description 1
- 206010061323 Optic neuropathy Diseases 0.000 description 1
- 201000010183 Papilledema Diseases 0.000 description 1
- 206010033712 Papilloedema Diseases 0.000 description 1
- 241000277263 Salmo Species 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000002790 cross-validation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000005043 peripheral vision Effects 0.000 description 1
- 238000000513 principal component analysis Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
Landscapes
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Data Mining & Analysis (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Eye Examination Apparatus (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23272609P | 2009-08-10 | 2009-08-10 | |
| US61/232,726 | 2009-08-10 | ||
| PCT/EP2010/004846 WO2011018193A2 (en) | 2009-08-10 | 2010-08-07 | Glaucoma combinatorial analysis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013501553A JP2013501553A (ja) | 2013-01-17 |
| JP2013501553A5 JP2013501553A5 (enExample) | 2013-09-12 |
| JP5923445B2 true JP5923445B2 (ja) | 2016-05-24 |
Family
ID=43357956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012524139A Active JP5923445B2 (ja) | 2009-08-10 | 2010-08-07 | 緑内障の組み合わせ解析 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20110190657A1 (enExample) |
| EP (1) | EP2465062B1 (enExample) |
| JP (1) | JP5923445B2 (enExample) |
| WO (1) | WO2011018193A2 (enExample) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080312552A1 (en) * | 2007-06-18 | 2008-12-18 | Qienyuan Zhou | Method to detect change in tissue measurements |
| US9357911B2 (en) * | 2011-05-09 | 2016-06-07 | Carl Zeiss Meditec, Inc. | Integration and fusion of data from diagnostic measurements for glaucoma detection and progression analysis |
| EP2602734A1 (en) * | 2011-12-08 | 2013-06-12 | Koninklijke Philips Electronics N.V. | Robust variant identification and validation |
| JP2013119019A (ja) * | 2011-12-09 | 2013-06-17 | Nidek Co Ltd | 視機能評価装置及び視機能評価プログラム |
| US20130218927A1 (en) * | 2012-02-17 | 2013-08-22 | Carl Zeiss Meditec, Inc. | Method for scaling ophthalmic imaging measurements to reflect functional disability risk |
| US10339464B2 (en) | 2012-06-21 | 2019-07-02 | Philip Morris Products S.A. | Systems and methods for generating biomarker signatures with integrated bias correction and class prediction |
| US9501823B2 (en) | 2012-08-02 | 2016-11-22 | Agency For Science, Technology And Research | Methods and systems for characterizing angle closure glaucoma for risk assessment or screening |
| US9420945B2 (en) * | 2013-03-14 | 2016-08-23 | Carl Zeiss Meditec, Inc. | User interface for acquisition, display and analysis of ophthalmic diagnostic data |
| EP2818098B1 (en) | 2013-06-25 | 2022-11-30 | Oculus Optikgeräte GmbH | Analysis method |
| US9883793B2 (en) | 2013-08-23 | 2018-02-06 | The Schepens Eye Research Institute, Inc. | Spatial modeling of visual fields |
| WO2015042476A1 (en) | 2013-09-20 | 2015-03-26 | Georgia Tech Research Corporation | Systems and methods for disease progression modeling |
| GB201407873D0 (en) * | 2014-05-02 | 2014-06-18 | Optos Plc | Improvements in and relating to imaging of the eye |
| WO2016116822A1 (en) * | 2015-01-19 | 2016-07-28 | Koninklijke Philips N.V. | Calibration of quantitative biomarker imaging |
| JP6898969B2 (ja) * | 2015-03-30 | 2021-07-07 | キヤノン株式会社 | 眼科情報処理システムおよび眼科情報処理方法 |
| JP6695171B2 (ja) * | 2016-03-04 | 2020-05-20 | 株式会社トプコン | 点眼容器モニタリングシステム |
| US20180014724A1 (en) * | 2016-07-18 | 2018-01-18 | Dariusz Wroblewski | Method and System for Analysis of Diagnostic Parameters and Disease Progression |
| EP3520038A4 (en) | 2016-09-28 | 2020-06-03 | D5A1 Llc | LEARNING TRAINER FOR MACHINE LEARNING SYSTEM |
| US9968251B2 (en) | 2016-09-30 | 2018-05-15 | Carl Zeiss Meditec, Inc. | Combined structure-function guided progression analysis |
| JPWO2018083853A1 (ja) * | 2016-11-02 | 2019-09-19 | 国立大学法人 東京大学 | 視野感度推定装置、視野感度推定装置の制御方法、及びプログラム |
| JP6489707B2 (ja) * | 2016-12-22 | 2019-03-27 | 義則 宮▲崎▼ | 緑内障のリスクレベルの判定補助方法、緑内障のリスクレベルを判定するための判定装置および判定プログラム |
| WO2018175098A1 (en) | 2017-03-24 | 2018-09-27 | D5Ai Llc | Learning coach for machine learning system |
| WO2018226492A1 (en) * | 2017-06-05 | 2018-12-13 | D5Ai Llc | Asynchronous agents with learning coaches and structurally modifying deep neural networks without performance degradation |
| WO2019021986A1 (ja) * | 2017-07-24 | 2019-01-31 | 国立大学法人東北大学 | 視野計 |
| WO2019073962A1 (ja) * | 2017-10-10 | 2019-04-18 | 国立大学法人 東京大学 | 画像処理装置及びプログラム |
| JP7178672B6 (ja) * | 2017-10-27 | 2022-12-20 | ビュノ インコーポレイテッド | 被検体に対する眼底映像の読取を支援する方法及びそれを利用した装置 |
| US11321612B2 (en) | 2018-01-30 | 2022-05-03 | D5Ai Llc | Self-organizing partially ordered networks and soft-tying learned parameters, such as connection weights |
| WO2019169166A1 (en) * | 2018-03-01 | 2019-09-06 | The Schepens Eye Research Institute, Inc. | Visual field progression |
| EP3758576A4 (en) * | 2018-03-02 | 2022-03-09 | Ohio State Innovation Foundation | SYSTEMS AND METHODS FOR MEASURING VISUAL FUNCTION MAPS |
| WO2019178100A1 (en) * | 2018-03-12 | 2019-09-19 | The Schepens Eye Research Institute, Inc. | Predicting result reversals of glaucoma hemifield tests |
| JP7446277B2 (ja) | 2018-03-13 | 2024-03-08 | ザ ユーエービー リサーチ ファンデーション | 網膜灌流及び視神経乳頭変形の共局在化検出 |
| CN108670192B (zh) * | 2018-04-21 | 2019-08-16 | 重庆贝奥新视野医疗设备有限公司 | 一种动态视觉刺激的多光谱眼底成像系统及方法 |
| EP3831275A4 (en) * | 2018-08-03 | 2022-04-27 | Nidek Co., Ltd. | Ophthalmic image processing device, oct device, and ophthalmic image processing program |
| US20210407096A1 (en) * | 2018-10-30 | 2021-12-30 | The Regents Of The University Of California | System for estimating primary open-angle glaucoma likelihood |
| CN109697716B (zh) * | 2018-12-19 | 2021-04-02 | 上海鹰瞳医疗科技有限公司 | 青光眼图像识别方法、设备和筛查系统 |
| CN109684981B (zh) * | 2018-12-19 | 2020-10-09 | 上海鹰瞳医疗科技有限公司 | 青光眼图像识别方法、设备和筛查系统 |
| US11191492B2 (en) * | 2019-01-18 | 2021-12-07 | International Business Machines Corporation | Early detection and management of eye diseases by forecasting changes in retinal structures and visual function |
| EP3690888B1 (en) | 2019-01-31 | 2025-07-02 | Nidek Co., Ltd. | Ophthalmologic image processing device and ophthalmologic image processing program |
| JP7343145B2 (ja) * | 2019-06-20 | 2023-09-12 | 国立大学法人 東京大学 | 情報処理装置、情報処理方法、及びプログラム |
| WO2021020419A1 (ja) * | 2019-07-29 | 2021-02-04 | 株式会社ニデック | 医療画像処理装置および医療画像処理プログラム |
| US11995521B2 (en) * | 2019-09-23 | 2024-05-28 | Dropbox, Inc. | Cross-model score normalization |
| US20240049960A1 (en) * | 2019-10-02 | 2024-02-15 | Massachusetts Eye And Ear Infirmary | Predicting clinical parameters relating to glaucoma from central visual field patterns |
| US12450746B2 (en) | 2020-02-07 | 2025-10-21 | The Uab Research Foundation | Retinal vascular stress test for diagnosis of vision-impairing diseases |
| KR20230003483A (ko) * | 2020-03-26 | 2023-01-06 | 다이아멘티스 인크. | 망막 신호 데이터를 처리하고 병태들을 식별하기 위한 시스템들 및 방법들 |
| JP7413147B2 (ja) * | 2020-05-21 | 2024-01-15 | キヤノン株式会社 | 画像処理装置、画像処理方法、及びプログラム |
| JP7644924B2 (ja) * | 2020-12-28 | 2025-03-13 | 株式会社トプコン | 眼科情報処理装置、眼科装置、眼科情報処理方法、及びプログラム |
| JP2025500291A (ja) * | 2021-12-16 | 2025-01-09 | クーレン ピーター | 初期段階緑内障を検出するための網膜電図を使用した機械学習ベースのフレームワーク |
| US20250078261A1 (en) * | 2022-01-20 | 2025-03-06 | Spectrawave, Inc. | Object detection and measurements in multimodal imaging |
| US11941809B1 (en) * | 2023-07-07 | 2024-03-26 | Healthscreen Inc. | Glaucoma detection and early diagnosis by combined machine learning based risk score generation and feature optimization |
| US12170147B1 (en) | 2023-07-07 | 2024-12-17 | iHealthScreen Inc. | Glaucoma detection and early diagnosis by combined machine learning based risk score generation and feature optimization |
| CN119745312B (zh) * | 2024-12-27 | 2025-11-21 | 上海人工智能创新中心 | 一种基于光学相干断层扫描的眼部指标预测方法和装置 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5381195A (en) * | 1993-03-22 | 1995-01-10 | Rootzen; Holger | Method and apparatus for testing a subject's perception of visual stimuli |
| US5461435A (en) * | 1993-05-05 | 1995-10-24 | Rootzen; Holger | Method and an apparatus for checking the thresholds of a subject's perception of visual stimuli |
| US5878746A (en) * | 1993-08-25 | 1999-03-09 | Lemelson; Jerome H. | Computerized medical diagnostic system |
| US6206829B1 (en) * | 1996-07-12 | 2001-03-27 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including network access |
| US5598235A (en) * | 1994-03-22 | 1997-01-28 | Heijl; Anders | Method and an apparatus for testing a subject's response to visual stimuli |
| JPH09313447A (ja) * | 1996-06-02 | 1997-12-09 | Topcon Corp | 眼底疾患に関する解析装置 |
| US6247812B1 (en) * | 1997-09-25 | 2001-06-19 | Vismed | System and method for diagnosing and treating a target tissue |
| US6068377A (en) * | 1999-05-14 | 2000-05-30 | Visionrx.Com, Inc. | Visual test utilizing color frequency doubling |
| WO2001028410A1 (en) * | 1999-10-21 | 2001-04-26 | Technolas Gmbh Ophthalmologische Systeme | Customized corneal profiling |
| AUPQ842800A0 (en) * | 2000-06-28 | 2000-07-20 | Aivision Pty Ltd | Flat screen vision testing |
| US6293674B1 (en) * | 2000-07-11 | 2001-09-25 | Carl Zeiss, Inc. | Method and apparatus for diagnosing and monitoring eye disease |
| EP1666009A3 (en) * | 2000-07-21 | 2007-08-22 | The Ohio State University | system for refractive ophthalmic surgery |
| US6735331B1 (en) * | 2000-09-05 | 2004-05-11 | Talia Technology Ltd. | Method and apparatus for early detection and classification of retinal pathologies |
| WO2002087431A1 (en) * | 2001-05-01 | 2002-11-07 | Structural Bioinformatics, Inc. | Diagnosing inapparent diseases from common clinical tests using bayesian analysis |
| US7166079B2 (en) * | 2002-01-23 | 2007-01-23 | Sensory Arts & Science, Llc | Methods and apparatus for observing and recording irregularities of the macula and nearby retinal field |
| US7458936B2 (en) * | 2003-03-12 | 2008-12-02 | Siemens Medical Solutions Usa, Inc. | System and method for performing probabilistic classification and decision support using multidimensional medical image databases |
| US7708403B2 (en) * | 2003-10-30 | 2010-05-04 | Welch Allyn, Inc. | Apparatus and method for diagnosis of optically identifiable ophthalmic conditions |
| US7575321B2 (en) * | 2003-10-30 | 2009-08-18 | Welch Allyn, Inc. | Apparatus and method of diagnosis of optically identifiable ophthalmic conditions |
| JP2005301816A (ja) * | 2004-04-14 | 2005-10-27 | Nidek Co Ltd | 医療情報処理システム及び該処理システムに用いるプログラム |
| US20060084856A1 (en) * | 2004-10-20 | 2006-04-20 | David Biggins | Combination ophthalmic instrument |
| US8971984B2 (en) * | 2005-04-04 | 2015-03-03 | Hypermed Imaging, Inc. | Hyperspectral technology for assessing and treating diabetic foot and tissue disease |
| US7942526B2 (en) * | 2006-01-23 | 2011-05-17 | Zeavision, Llc. | Diagnostic, prescriptive, and data-gathering system and method for macular pigment deficits and other eye disorders |
| US20070197932A1 (en) * | 2006-02-17 | 2007-08-23 | Feke Gilbert T | Non-invasive methods for evaluating retinal affecting neurodegenerative diseases |
| JP5011495B2 (ja) * | 2006-05-31 | 2012-08-29 | 株式会社ニデック | 眼科装置 |
| JP5007420B2 (ja) * | 2006-09-21 | 2012-08-22 | タック株式会社 | 画像解析システム、及び画像解析プログラム |
| CA2690834C (en) * | 2007-06-15 | 2015-08-18 | University Of Southern California | Pattern analysis of retinal maps for the diagnosis of optic nerve diseases by optical coherence tomography |
| US20080312552A1 (en) * | 2007-06-18 | 2008-12-18 | Qienyuan Zhou | Method to detect change in tissue measurements |
| CA2706385C (en) * | 2007-07-17 | 2015-11-17 | Heidelberg Engineering Gmbh | Method and apparatus for evaluating the field of vision |
| US7798647B2 (en) * | 2007-09-18 | 2010-09-21 | Carl Zeiss Meditec, Inc. | RNFL measurement analysis |
| DE102007052282A1 (de) * | 2007-11-02 | 2009-05-07 | Carl Zeiss Meditec Ag | Verfahren und Vorrichtung zum Ermitteln und Darstellen von medizinischen Informationen |
| US10064548B2 (en) * | 2007-11-09 | 2018-09-04 | The Australian National University | Method and apparatus for sensory field assessment |
| US7406200B1 (en) * | 2008-01-08 | 2008-07-29 | International Business Machines Corporation | Method and system for finding structures in multi-dimensional spaces using image-guided clustering |
| US8348429B2 (en) * | 2008-03-27 | 2013-01-08 | Doheny Eye Institute | Optical coherence tomography device, method, and system |
| US8132916B2 (en) * | 2008-12-12 | 2012-03-13 | Carl Zeiss Meditec, Inc. | High precision contrast ratio display for visual stimulus |
| JP5543126B2 (ja) * | 2009-04-16 | 2014-07-09 | キヤノン株式会社 | 医用画像処理装置及びその制御方法 |
| US7905599B2 (en) * | 2009-04-30 | 2011-03-15 | University Of Southern California | Methods for diagnosing glaucoma utilizing combinations of FD-OCT measurements from three anatomical regions of the eye |
| US8256897B2 (en) * | 2009-05-14 | 2012-09-04 | Topcon Medical Systems, Inc. | Circular profile mapping and display of retinal parameters |
| US9357911B2 (en) * | 2011-05-09 | 2016-06-07 | Carl Zeiss Meditec, Inc. | Integration and fusion of data from diagnostic measurements for glaucoma detection and progression analysis |
-
2010
- 2010-08-03 US US12/849,686 patent/US20110190657A1/en not_active Abandoned
- 2010-08-07 JP JP2012524139A patent/JP5923445B2/ja active Active
- 2010-08-07 EP EP10750034.0A patent/EP2465062B1/en active Active
- 2010-08-07 WO PCT/EP2010/004846 patent/WO2011018193A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20110190657A1 (en) | 2011-08-04 |
| JP2013501553A (ja) | 2013-01-17 |
| WO2011018193A3 (en) | 2011-05-12 |
| WO2011018193A2 (en) | 2011-02-17 |
| EP2465062B1 (en) | 2017-12-06 |
| EP2465062A2 (en) | 2012-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5923445B2 (ja) | 緑内障の組み合わせ解析 | |
| Christopher et al. | Deep learning approaches predict glaucomatous visual field damage from OCT optic nerve head en face images and retinal nerve fiber layer thickness maps | |
| Reus et al. | Accuracy of GDx VCC, HRT I, and clinical assessment of stereoscopic optic nerve head photographs for diagnosing glaucoma | |
| Kuang et al. | Estimating lead time gained by optical coherence tomography in detecting glaucoma before development of visual field defects | |
| Zangwill et al. | A comparison of optical coherence tomography and retinal nerve fiber layer photography for detection of nerve fiber layer damage in glaucoma | |
| Hood et al. | Structure-function agreement is better than commonly thought in eyes with early glaucoma | |
| Vessani et al. | Comparison of quantitative imaging devices and subjective optic nerve head assessment by general ophthalmologists to differentiate normal from glaucomatous eyes | |
| Huang et al. | Development and comparison of automated classifiers for glaucoma diagnosis using Stratus optical coherence tomography | |
| Kamal et al. | Use of sequential Heidelberg retina tomograph images to identify changes at the optic disc in ocular hypertensive patients at risk of developing glaucoma | |
| Medeiros et al. | Comparison of the gdx vcc scanning laser polarimeter, hrt ii confocalscanning laser ophthalmoscope, and stratus oct optical coherence tomographfor the detection of glaucoma | |
| Mwanza et al. | Ability of cirrus HD-OCT optic nerve head parameters to discriminate normal from glaucomatous eyes | |
| Nouri-Mahdavi et al. | Identifying early glaucoma with optical coherence tomography | |
| US9357911B2 (en) | Integration and fusion of data from diagnostic measurements for glaucoma detection and progression analysis | |
| Huang et al. | Glaucoma detection using adaptive neuro-fuzzy inference system | |
| Manassakorn et al. | Comparison of retinal nerve fiber layer thickness and optic disk algorithms with optical coherence tomography to detect glaucoma | |
| Bowd et al. | Gradient-boosting classifiers combining vessel density and tissue thickness measurements for classifying early to moderate glaucoma | |
| Kim et al. | Spectral-domain optical coherence tomography for detection of localized retinal nerve fiber layer defects in patients with open-angle glaucoma | |
| Ferreras et al. | Diagnostic ability of Heidelberg Retina Tomograph 3 classifications: glaucoma probability score versus Moorfields regression analysis | |
| US20110022553A1 (en) | Diagnosis support system, diagnosis support method therefor, and information processing apparatus | |
| Porporato et al. | Towards ‘automated gonioscopy’: a deep learning algorithm for 360 angle assessment by swept-source optical coherence tomography | |
| Ferreras et al. | Discriminating between normal and glaucoma-damaged eyes with the Heidelberg Retina Tomograph 3 | |
| Ferreras et al. | Diagnostic ability of the Heidelberg Retina Tomograph 3 for glaucoma | |
| Leung et al. | American Chinese glaucoma imaging study: a comparison of the optic disc and retinal nerve fiber layer in detecting glaucomatous damage | |
| Elbendary et al. | Discriminating ability of spectral domain optical coherence tomography in different stages of glaucoma | |
| Christopher et al. | Novel technologies in artificial intelligence and telemedicine for glaucoma screening |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130724 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130724 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140228 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140304 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140603 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140610 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140728 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150106 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150929 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151224 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160329 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160418 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5923445 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |